Fennec Financial Statements From 2010 to 2025

Fennec Pharmaceuticals Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 47.2 M 44.9 M 17.7 M Slightly volatile Short and Long Term Debt Total 14.7 M 19.3 M 9.1 M Slightly volatile Other Current Liabilities 2.2 M 3.4 M 2 M Pretty Stable Total Current Liabilities 7.3 M 6.9 M 3.4 M Slightly volatile Property Plant And Equipment Net 552.5 K 484.1 K 419.8 K Slightly volatile Accounts Payable 3.4 M 3.2 M 1.3 M Slightly volatile Cash 28 M 26.6 M 14 M Slightly volatile Cash And Short Term Investments 28 M 26.6 M 14 M Slightly volatile Common Stock Shares Outstanding 28.7 M 27.3 M 17.1 M Slightly volatile Liabilities And Stockholders Equity 47.2 M 44.9 M 17.7 M Slightly volatile Other Current Assets 3.7 M 3.5 M 781.8 K Slightly volatile Other Stockholder Equity 59.8 M 67 M 49.8 M Slightly volatile Total Liabilities 53.4 M 50.8 M 12.9 M Slightly volatile Property Plant And Equipment Gross 552.5 K 484.1 K 419.8 K Slightly volatile Total Current Assets 46.3 M 44.1 M 17.5 M Slightly volatile Short Term Investments 1 M 1.1 M 1.4 M Slightly volatile Intangible Assets 9.6 M 9 M 10.1 M Slightly volatile Common Stock Total Equity 95.3 M 161.8 M 100.7 M Slightly volatile Common Stock 113.1 M 145.6 M 101.2 M Slightly volatile Short and Long Term Debt 142.8 K 150.3 K 510.8 K Slightly volatile Capital Surpluse 56 M 67 M 48.3 M Slightly volatile Cash And Equivalents 22 M 24.6 M 14.1 M Slightly volatile Net Invested Capital 16.5 M 13.5 M 23 M Slightly volatile Net Working Capital 25.9 M 37.2 M 25.1 M Pretty Stable Capital Stock 145.6 M 145.6 M 120.2 M Slightly volatile Deferred Long Term Liabilities 133.3 K 189.9 K 213.7 K Slightly volatile Other Liabilities 222.3 K 234 K 3.8 M Slightly volatile Long Term Debt 22 M 19.3 M 9.8 M Slightly volatile
Fennec Pharmaceuticals Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Selling General Administrative 24.2 M 23.1 M 8.8 M Slightly volatile Other Operating Expenses 47.2 M 45 M 14.6 M Slightly volatile Research Development 291.6 K 307 K 2.1 M Pretty Stable Total Operating Expenses 43.9 M 41.8 M 14.1 M Slightly volatile Interest Income 2.8 M 2.6 M 909.4 K Very volatile Reconciled Depreciation 840 K 800 K 195.9 K Slightly volatile Selling And Marketing Expenses 12.2 M 18.4 M 4.9 M Slightly volatile
Fennec Pharmaceuticals Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Begin Period Cash Flow 10.8 M 13.3 M 11.7 M Slightly volatile End Period Cash Flow 28 M 26.6 M 14 M Slightly volatile Stock Based Compensation 5.3 M 5.1 M 2.2 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 3.45 3.6286 596.3 K Slightly volatile Days Sales Outstanding 93.98 98.9242 1 M Slightly volatile Average Payables 1 M 1.4 M 1.5 M Pretty Stable Stock Based Compensation To Revenue 0.1 0.1065 11.9991 Slightly volatile Capex To Depreciation 0.0999 0.11 0.1263 Slightly volatile EV To Sales 3.3 3.4752 591.4 K Slightly volatile Sales General And Administrative To Revenue 0.46 0.4849 53.9341 Slightly volatile Average Inventory 226.8 K 216 K 222.7 K Slightly volatile Research And Ddevelopement To Revenue 0.0061 0.0065 86.9 K Slightly volatile Cash Per Share 0.93 0.9758 0.6955 Slightly volatile Intangibles To Total Assets 0.44 0.54 0.5801 Pretty Stable Current Ratio 5.11 6.3772 6.3326 Slightly volatile Receivables Turnover 3.87 3.6897 1.3683 Slightly volatile Average Receivables 120.4 K 92.4 K 87.2 K Very volatile Revenue Per Share 1.83 1.7417 0.285 Slightly volatile Interest Debt Per Share 0.9 0.8577 0.2715 Slightly volatile Debt To Assets 0.38 0.4303 0.3392 Slightly volatile Operating Cycle 209 220 1 M Slightly volatile Long Term Debt To Capitalization 0.76 1.3981 0.4959 Slightly volatile Total Debt To Capitalization 1.47 1.398 0.5491 Slightly volatile Quick Ratio 5.06 6.224 6.2942 Slightly volatile Net Income Per E B T 5.8 5.53 1.8884 Slightly volatile Cash Ratio 4.42 3.8494 6.304 Slightly volatile Days Of Sales Outstanding 93.98 98.9242 1 M Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.13 1.15 1.0203 Slightly volatile Fixed Asset Turnover 0.0 0.0 0.0 Slightly volatile Debt Ratio 0.38 0.4303 0.3392 Slightly volatile Price Sales Ratio 3.45 3.6286 596.3 K Slightly volatile Asset Turnover 1.11 1.0577 0.1954 Slightly volatile Gross Profit Margin 0.89 0.933 5.2 K Slightly volatile
Fennec Pharmaceuticals Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 145.6 M 131.6 M 135.3 M Slightly volatile Enterprise Value 121.1 M 113.1 M 112.5 M Slightly volatile

Fennec Fundamental Market Drivers

About Fennec Pharmaceuticals Financial Statements

Pair Trading with Fennec Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Fennec Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fennec Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.When determining whether Fennec Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fennec Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fennec Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fennec Pharmaceuticals Stock:

How To Invest In Fennec Details

Is Fennec Stock a good investment? Details

What is Fennec Pharmaceuticals' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Intrinsic Valuation Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details

Please note, there is a significant difference between Fennec Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fennec Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fennec Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.